Neurology

David Perry, MD

Associate Professor

Dr. Perry graduated from medical school at Georgetown University in Washington, DC. He completed an internship in internal medicine and residency in neurology at the Mayo Clinic in Rochester, Minnesota where he also researched obsessive-compulsive features in dementia. He is an Assistant Professor of Neurology at the Memory and Aging Center and participates in the evaluation and treatment of patients in the MAC clinic.

His current area of research interest is the impact of neurodegenerative illness on reward processing.

Adam Boxer, MD, PhD

Professor

Adam L. Boxer, MD, PhD, is Endowed Professor in Memory and Aging in the Department of Neurology at the University of California, San Francisco (UCSF). He directs UCSF’s Neurosciences Clinical Research Unit and the Alzheimer’s Disease and Frontotemporal Degeneration (FTD) Clinical Trials Program at the UCSF Memory and Aging Center. Dr.

Alissa Nana Li, PhD

Associate Lab Specialist

Alissa joined the Seeley Selective Vulnerability Research Laboratory in 2011 as a postdoctoral fellow. Her background is in neurodegeneration research. Alissa completed a BSc degree with honors in biomedical science in 2004 and a PhD degree in anatomy in 2009 from the University of Auckland, New Zealand, where she investigated the variable pattern of cortical neuronal loss in Huntington’s disease.

Stephanie Gaus, PhD

Research Scientist

Stephanie joined the Seeley Selective Vulnerability Research Laboratory in October 2007 as an Associate Specialist. Her background is in sleep and circadian rhythms research, including neuroanatomy. She completed a doctorate in neurobiology (CB Saper, Harvard University), a master's in medical science (Harvard Medical School), and a postdoc focusing on narcolepsy (E Mignot, Stanford University/Howard Hughes Medical Institute).

Shireen Javandel

Assistant Director for Operations and Impact, GBHI

Shireen provides oversight for resource allocation, risk mitigation, budgeting, and logistics for the Global Brain Health Institute (GBHI) at the UCSF Memory and Aging Center. She works closely with the Department of Neurology and other groups to optimize the administration of the program within UCSF.

Peter Ljubenkov, MD

Assistant Professor

Dr. Peter A. Ljubenkov is a behavioral neurologist at the UCSF Memory and Aging Center and specializes in caring for patients experiencing memory, language and behavioral changes due to neurological conditions, such as Alzheimer’s disease, Lewy body dementia, and other causes of dementia.

Melanie Stephens, PhD

Clinic Director

Dr. Melanie Stephens directs the Memory and Aging Center Clinic and is an Assistant Professor of Neuropsychology.

Mary Koestler, RN, PhD

Project Administrator and Trials Nurse

Mary Koestler joined the Memory and Aging Center’s clinical trials unit as project administrator and trials nurse in July 2007. Dr. Koestler completed a master’s degree in nursing with an emphasis in clinical research management at UCSF followed by a PhD degree. She currently manages industry-sponsored FDA Phase I-III Alzheimer’s disease trials. Dr. Koestler is credentialed by the Association of Clinical Research Professionals (ACRP).

Marilu Gorno Tempini, MD, PhD

Professor of Neurology and Psychiatry

Dr. Maria Luisa Gorno Tempini is a behavioral neurologist and holds the Charles Schwab Charles Schwab Distinguished Professorship in Dyslexia and Neurodevelopment. She currently directs the Language Neurobiology Laboratory at the UCSF Memory and Aging Center and co-directs the UCSF Dyslexia Center. She obtained her medical degree and clinical neurology specialty training in Italy and has a doctorate in the neuroimaging of language from University College London.

Katherine Possin, PhD

John Douglas French Alzheimer’s Foundation Endowed Professorship
Professor

Dr. Possin’s research program is focused on improving the detection, diagnosis and care for people with neurodegenerative disease. She has long-standing interests in understanding the cognitive impairments and their neural bases in neurodegenerative diseases including Alzheimer’s disease, Lewy body disease, Huntington’s disease, chronic traumatic encephalopathy and frontotemporal lobar degeneration.

Pages